Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review, 11676 [2015-04411]
Download as PDF
<![CDATA[
mstockstill on DSK4VPTVN1PROD with NOTICES
11676
Federal Register / Vol. 80, No. 42 / Wednesday, March 4, 2015 / Notices
announces the following meeting of the
aforementioned committee:
Times and Dates:
10:00 a.m.–5:00 p.m., EDT, March 25,
2015
8:00 a.m.–3:30 p.m., EDT, March 26,
2015
Place: Centers for Disease Control and
Prevention (CDC), Global
Communications Center, Building 19,
Auditorium B3, 1600 Clifton Road NE.,
Atlanta, Georgia 30333
Status: Open to the public limited
only by the space available. The meeting
room will accommodate up to 90
people. Public participants should preregister for the meeting as described in
Additional Information for Public
Participants. Members of the public that
wish to attend this meeting should preregister by submitting the following
information by email, facsimile, or
phone (see Contact Person for More
Information) no later than 12:00 noon
(EDT) on Tuesday, March 17, 2015:
• Full Name
• Organizational Affiliation
• Complete Mailing Address
• Citizenship
• Phone Number or Email Address
Purpose: This Board is charged with
providing advice and guidance to the
Secretary, Department of Health and
Human Services (HHS), the Assistant
Secretary for Health (ASH), the Director,
Centers for Disease Control and
Prevention (CDC), and the Director,
Office of Public Health Preparedness
and Response (OPHPR), concerning
strategies and goals for the programs
and research within OPHPR, monitoring
the overall strategic direction and focus
of the OPHPR Divisions and Offices,
and administration and oversight of
peer review of OPHPR scientific
programs. For additional information
about the Board, please visit: https://
www.cdc.gov/phpr/science/
counselors.htm.
Matters for Discussion: Day one of the
meeting will cover briefings and BSC
deliberation on the following topics:
Interval updates from OPHPR Divisions
and Offices; key issues associated with
CDC’s response to the Ebola outbreak;
mental and behavioral health and
emergency preparedness and response;
and BSC liaison representative updates
to the Board highlighting organizational
activities relevant to the OPHPR
mission.
Day two of the meeting will cover
briefings and BSC deliberation on the
following topics: Hurricane Sandy
Recovery Research Initiative overview;
select agent regulations; National Health
Security Preparedness Index Update;
and OPHPR impact measurement.
VerDate Sep<11>2014
18:11 Mar 03, 2015
Jkt 235001
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information:
Sparkle Buissereth, Executive Assistant,
Office of Science and Public Health
Practice, Centers for Disease Control and
Prevention, 1600 Clifton Road NE.,
Mailstop D–44, Atlanta, Georgia 30333,
Telephone: (404) 639–7325; Facsimile:
(404) 639–7977; Email:
OPHPR.BSC.Questions@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities for both the
Centers for Disease Control and
Prevention, and Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2015–04466 Filed 3–3–15; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
The meeting announced below
concerns Public Health Research on
Modifiable Risk Factors for Spina
Bifida, DD15–001, initial review.
This document corrects a
notice that was published in the Federal
Register on February 18, 2015 Volume
80, Number 32, pages 8661. The time
and date should read as follows:
Time And Date: 11:00 a.m.–6:00 p.m.,
March 19, 2015 (Closed).
SUMMARY:
FOR FURTHER INFORMATION CONTACT:
M. Chris Langub, Ph.D., Scientific
Review Officer, CDC, 4770 Buford
Highway NE., Mailstop F46, Atlanta,
Georgia 30341, Telephone: (770) 488–
3585, EEO6@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
PO 00000
Frm 00048
Fmt 4703
Sfmt 9990
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2015–04469 Filed 3–3–15; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces a meeting for the initial
review of applications in response to
DP15–006, Investigating New
Approaches for Tobacco Surveillance
Systems.
Time and Date: 11:00 a.m.–6:30 p.m.,
March 24, 2015 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c) (4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters for Discussion: The meeting will
include the initial review, discussion, and
evaluation of applications received in
response to ‘‘Investigating New Approaches
for Tobacco Surveillance Systems’’, DP15–
006.
Contact Person for More Information: M.
Chris Langub, Ph.D., Scientific Review
Officer, CDC, 4770 Buford Highway, NE.,
Mailstop F–80, Atlanta, Georgia 30341,
Telephone: (770) 488–3585, EEO6@cdc.gov.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Catherine Ramadei,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2015–04411 Filed 3–3–15; 8:45 am]
BILLING CODE 4163–18–P
E:\FR\FM\04MRN1.SGM
04MRN1
]]>Agencies
[Federal Register Volume 80, Number 42 (Wednesday, March 4, 2015)]
[Notices]
[Page 11676]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2015-04411]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special
Emphasis Panel (SEP): Initial Review
In accordance with Section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces a meeting for the initial review of
applications in response to DP15-006, Investigating New Approaches for
Tobacco Surveillance Systems.
Time and Date: 11:00 a.m.-6:30 p.m., March 24, 2015 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the public in accordance
with provisions set forth in Section 552b(c) (4) and (6), Title 5
U.S.C., and the Determination of the Director, Management Analysis
and Services Office, CDC, pursuant to Public Law 92-463.
Matters for Discussion: The meeting will include the initial
review, discussion, and evaluation of applications received in
response to ``Investigating New Approaches for Tobacco Surveillance
Systems'', DP15-006.
Contact Person for More Information: M. Chris Langub, Ph.D.,
Scientific Review Officer, CDC, 4770 Buford Highway, NE., Mailstop
F-80, Atlanta, Georgia 30341, Telephone: (770) 488-3585,
EEO6@cdc.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention
and the Agency for Toxic Substances and Disease Registry.
Catherine Ramadei,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention.
[FR Doc. 2015-04411 Filed 3-3-15; 8:45 am]
BILLING CODE 4163-18-P
